Dow Up 0.07% Nasdaq Up 0.61%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.90 Up 0.01(1.13%) Nov 26, 3:59PM EST
Prev Close:0.89
Open:0.91
Bid:0.84 x 900
Ask:N/A
1y Target Est:5.00
Beta:2.13
Next Earnings Date:N/A
Day's Range:0.88 - 0.93
52wk Range:0.73 - 2.20
Volume:66,059
Avg Vol (3m):188,303
Market Cap:25.36M
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OPXA

Comparison

Symbol% ChgMkt Cap
OPXAUp 1.13%25.36M
SNYUp 0.92%126.20B
TEVAUp 0.41%48.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.58
Quarterly EPS Est (Dec-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback